Cryptogenic Stroke and Antiplatelet Therapy
The majority of the time, a blood clot that prevents blood flow to the brain is what causes a stroke. However, sometimes the cause cannot be identified despite testing. Strokes with an unknown aetiology are known as cryptogenic strokes. Therefore, further investigation is required to arrive at a conclusive diagnosis. Researchers from the fields of electrophysiology, cardiology, and neurology may work together to find the solutions needed to develop the tailored therapy for preventing repeated strokes. A group of drugs called antiplatelets prevent blood cells from congregating and creating a blood clot. Platelets are transported to the site of an injury whenever it occurs in your body, where they cluster together to form a blood clot. This stops the bodily bleeding.
Patients are usually given antiplatelets if they have a history of Coronary artery disease (CAD), Heart attack, Angina,Stroke or transient ischemic attacks (TIAs), Peripheral vascular disease (PVD).